<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>75(1)</volume><submitter>Frank CG</submitter><pubmed_abstract>Defects of lipid-linked oligosaccharide assembly lead to alterations of N-linked glycosylation known as "type I congenital disorders of glycosylation" (CDG). Dysfunctions along this stepwise assembly pathway are characterized by intracellular accumulation of intermediate lipid-linked oligosaccharides, the detection of which contributes to the identification of underlying enzymatic defects. Using this approach, we have found, in a patient with CDG, a deficiency of the ALG9 alpha 1,2 mannosyltransferase enzyme, which causes an accumulation of lipid-linked-GlcNAc(2)Man(6) and -GlcNAc(2)Man(8) structures, which was paralleled by the transfer of incomplete oligosaccharides precursors to protein. A homozygous point-mutation 1567G-->A (amino acid substitution E523K) was detected in the ALG9 gene.</pubmed_abstract><journal>American journal of human genetics</journal><pagination>146-50</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC1181998</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL.</pubmed_title><pmcid>PMC1181998</pmcid><pubmed_authors>Aebi M</pubmed_authors><pubmed_authors>Berger EG</pubmed_authors><pubmed_authors>Grubenmann CE</pubmed_authors><pubmed_authors>Hennet T</pubmed_authors><pubmed_authors>Frank CG</pubmed_authors><pubmed_authors>Eyaid W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL.</name><description>Defects of lipid-linked oligosaccharide assembly lead to alterations of N-linked glycosylation known as "type I congenital disorders of glycosylation" (CDG). Dysfunctions along this stepwise assembly pathway are characterized by intracellular accumulation of intermediate lipid-linked oligosaccharides, the detection of which contributes to the identification of underlying enzymatic defects. Using this approach, we have found, in a patient with CDG, a deficiency of the ALG9 alpha 1,2 mannosyltransferase enzyme, which causes an accumulation of lipid-linked-GlcNAc(2)Man(6) and -GlcNAc(2)Man(8) structures, which was paralleled by the transfer of incomplete oligosaccharides precursors to protein. A homozygous point-mutation 1567G-->A (amino acid substitution E523K) was detected in the ALG9 gene.</description><dates><release>2004-01-01T00:00:00Z</release><publication>2004 Jul</publication><modification>2025-04-04T21:07:08.75Z</modification><creation>2019-03-27T01:09:11Z</creation></dates><accession>S-EPMC1181998</accession><cross_references><pubmed>15148656</pubmed><doi>10.1086/422367</doi></cross_references></HashMap>